life scienc tool diagnost
ep ahead consensu ep beat
lower revenu off-set better profit rais
ep guidanc midpoint vs con
reflect beat increment better profit experi
balanc year partial off-set higher tax rate importantli
maintain intern sale growth guidanc rais
ep upsid strengthen profit
experi partial off-set tax headwind tp move
ebitda higher view
consum caviti equip rebound profit revenu
declin ex-met plan intern growth
vs estimate driven equip/technolog vs estimate
reflect innov primescan benefit destock
million implant growth meanwhil consum disappoint
drop vs estimate albeit somewhat difficult comp
neg growth across geographi intern sale
europ rose vs estimate row rose vs estimate
nice view meanwhil us vs estimate
anem oper margin expand bp bp view
flow million fund million dividend note
dividend hike announc report share purchas million
pre-cal view share rise top-line dynam mix
equip trend better fear impress
healthi profit experi consequ view print enough
share climb higher latest oper upsid said
consum notabl lacklust await greater call commentari
underli geograph dynam read-through broader dental
demand trend broadli task hand daunt
term lt growth aspir cost structur complex see
turnaround aggress
restructur plan underway risk includ demand shift execut
meaning
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
dentspli design develop manufactur market
price aug rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
better fundament perform sentiment could drive upsid
target price blue sky scenario
weaker fundament perform sentiment could lead
downsid versu target price grey sky scenario
 close
compani mention price
